approval
saveTOPIRAMATE — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 6, 2026 · 218d ago
- approvalTOPIRAMATE — FDA approvalJan 27, 2026 · 256d ago
- approvalTOPIRAMATE — FDA approvalJan 18, 2026 · 265d ago
- approvalTOPIRAMATE — FDA approvalJan 12, 2026 · 271d ago
- approvalTOPIRAMATE — FDA approvalDec 4, 2025 · 310d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 12, 2025 · 577d ago
- approvalTOPIRAMATE — FDA approvalJul 16, 2024 · 816d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMay 17, 2024 · 876d ago
same company · ±60 days · 6
- approvalNAPROXEN: NAPROXEN — FDA approvalOct 3, 2025
- approvalALDACTAZIDE: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalSep 30, 2025
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalSep 30, 2025
- approvalolanzapine ODT: OLANZAPINE — FDA approvalOct 23, 2025
- approvalondansetron hydrochloride CR: ONDANSETRON HYDROCHLORIDE — FDA approvalOct 23, 2025
- approvalLINAGLIPTIN: LINAGLIPTIN — FDA approvalNov 3, 2025
comments(0)
5-min edit window · permanent after that